Clinical Trial Update: Study to Assess the Safety and Efficacy of Infliximab to Treat Hidradenitis Suppurtativa [Phase 2]

View source ↗

Summary

Phase 2 study evaluating safety and efficacy of infliximab for hidradenitis suppurativa has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• Infliximab (Remicade) (Infliximab)

Snippet

Sponsor: Florida Academic Dermatology Centers | Conditions: Hidradenitis Suppurativa | Phase 2 | Status: COMPLETED